Rawls Palmer Progress in Medicine Award Presented to Dr. Scott A. Waldman

Scott A. Waldman, M.D., Ph.D., will receive the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Rawls–Palmer Progress in Medicine Award at the 2012 Annual Meeting on March 16.

Scott A. Waldman, M.D., Ph.D., will receive the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Rawls–Palmer Progress in Medicine Award at the 2012 Annual Meeting on March 16.

Established in 1978 by Dr. W. B. Rawls, the award recognizes scientists who have implemented progressive research techniques and tools to improve patient care.

ASCPT will present the award to Dr. Waldman prior to his lecture at the 113th Annual Meeting.

Dr. Waldman is the Samuel MV Hamilton Endowed Professor of Medicine, Vice President of Clinical and Translational Research, and Chair of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University. He is also Director of the Gastrointestinal Malignancies Program at the university’s Kimmel Cancer Center and Associate Dean of Clinical and Translational Sciences at Jefferson Medical College.

As a longtime volunteer leader of ASCPT, Dr. Waldman has participated on various committees and task forces, serving on the Board of Directors, as Society president, and as Editor in Chief of Clinical Pharmacology and Therapeutics since 2006.

Dr. Waldman has chaired numerous scientific review panels for the NIH and is on the editorial boards of Personalized Medicine, Expert Reviews in Clinical Pharmacology, and Regenerative Medicine, among others. He is the inaugural Deputy Editor of Clinical and Translational Science and the inaugural Senior Editor of Biomarkers in Medicine.

Dr. Waldman is a recognized clinician–investigator whose research ranges from molecular biology to cancer diagnostics and therapeutics. He received the 2010 ASCPT Henry Elliott Award and the 2011 Pharmaceutical Research and Manufacturers of America Foundation Award in Excellence for Clinical Pharmacology and Therapeutics.

About ASCPT

ASCPT is the leading forum for the discussion, development, and integration of clinical pharmacology in the drug development continuum—from discovery to safe and effective use. Headquartered in Alexandria, Virginia, ASCPT was established in 1900. Today, more than 2,100 ASCPT members are committed to advancing the science of human pharmacology and therapeutics worldwide.

*This release was reprinted with permission from ASCPT.

For more information, contact: Steve Graff, Thomas Jefferson University and Hospitals, 211 South 9th Street, Suite 310, Philadelphia, PA 19107, (215) 955-5291, (215) 955-5008 fax, or email stephen.graff@jefferson.edu.

Published: 04-26-2012

Close Window